Dr. Joseph Lee Roswarski, MD

  • Washington, DC
  • Hematologist and oncologist
NPI1215223839PAC ID4789801358
Medicare services, 2024
695
Medicare patients, 2024
132
Part D claims, 2024
120
Publications
18
MIPS score, 2024
81
Practice address
3800 Reservoir NW Rd, Washington, DC 20007
Practice phone
Call (202) 444-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Medstar Georgetown Medical Center

Washington, District of Columbia

See all 6 affiliations

Find Dr. Roswarski's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Joseph Lee Roswarski is a hematologist and oncologist in Washington, District of Columbia

Dr. Roswarski practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Roswarski's NPI, 1215223839, was assigned on June 22, 2011. Dr. Roswarski graduated from Indiana University School Of Medicine in 2011. Dr. Roswarski holds District of Columbia license MD210002210.

NPI and contact details
Medicare PAC ID
4789801358
NPI enumeration date
June 22, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(202) 444-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Joseph Lee Roswarski practices at Medstar Georgetown Medical Center in Washington, District of Columbia

Dr. Roswarski's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-3000.

  • Medstar Georgetown Medical Center
    3800 Reservoir NW Rd, Washington, DC 20007 · District Of Columbia CountyPhone(202) 444-3000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Joseph Lee Roswarski is affiliated with 4 sites of care and 2 medical groups

Dr. Roswarski's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Roswarski is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Roswarski to 2 more hospitals and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Roswarski

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Joseph Lee Roswarski's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roswarski practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Medstar Georgetown Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Roswarski practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Joseph Lee Roswarski is one of 66 hematologists and oncologists in District of Columbia

Hematology and oncology is Dr. Roswarski's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Roswarski is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Roswarski's licenses on file in 3 states: District of Columbia, Virginia and Maryland.

Specialties and state licenses

  • Hematology and oncology, District of ColumbiaPrimaryLicense MD210002210 · 2022 to 2026 · taxonomy 207RH0003X
  • Internal medicine, VirginiaLicense 0101254676 · 2013 to 2026 · taxonomy 207R00000X
  • Maryland license2022 to 2025

Clinical focus

Dmand AI lists lymphoma among the conditions Dr. Roswarski treats.

Hematologists and oncologists near Dr. Roswarski

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Joseph Lee Roswarski billed Medicare for 695 services in 2024

CMS data shows 695 Medicare services from Dr. Roswarski across 7 procedure codes in 2024, for 132 Medicare patients. Medicare paid $61,382 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024695
Medicare patients132
Paid by Medicare$61,382
Procedure codes7

Dr. Roswarski's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4222024: 53226%
Other services
2023: 02024: 163

Dr. Roswarski compared with the District of Columbia median for hematologists and oncologists, 2024

  • Dr. Roswarski
  • District of Columbia median
Medicare services
695vs 39676% above
Medicare patients
132vs 14911% below
Part D claims
38vs 11467% below

Medians across 62 hematologists and oncologists in District of Columbia with Dmand AI profiles that report each measure.

Dr. Roswarski's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Roswarski

Need commercial claims for Dr. Roswarski?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Roswarski and other hematologists and oncologists in District of Columbia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Joseph Lee Roswarski treated 132 Medicare patients in 2024, average age 74

CMS counts 132 Medicare patients who saw Dr. Roswarski in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roswarski's median patient age at 66, with 44% women.

Medicare patients, 2024132
Average age74
Average risk score1.98
Also on Medicaid18%

Dr. Roswarski's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Roswarski's Medicare patients by sex, 2024

  • Women6448%
  • Men6852%

Chronic conditions among Dr. Roswarski's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis52%
  4. Ischemic heart disease44%
  5. Diabetes36%
  6. Anxiety31%
  7. Chronic kidney disease31%
  8. Heart failure27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Roswarski's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women44%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Joseph Lee Roswarski wrote 120 Medicare Part D claims in 2024

In 2024, Dr. Roswarski wrote 120 Medicare Part D claims for 31 patients. 59% of them were for generic drugs. CMS names the drug for 38 of them, across 2 drugs with 11 or more claims each, at $369,794 in total drug cost. In 2023, CMS named 23 claims across 1 drug.

Part D claims, 2024120
Drugs named by CMS2
Total drug cost$369,794
Part D patients31

Dr. Roswarski's Part D claims by kind of drug, 2024

  • Generic71 claims59%
  • Brand-name49 claims41%

Dr. Roswarski's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 232024: 3865%

Drugs named by CMS: 2 in 2024, 1 in 2023.

See all prescribing by Dr. Roswarski

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Joseph Lee Roswarski scored 81 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Roswarski for performance year 2024. Dr. Roswarski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roswarski as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Roswarski's MIPS scores, performance year 2024

  • 81of 100Final score
  • 51.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Roswarski by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Joseph Lee Roswarski has 18 publications on record

Dmand AI links 18 papers to Dr. Roswarski, published from 2015 to 2023. 2020 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, COVID-19 and Multiple Myeloma. Dr. Roswarski has published most often in Case Rep Oncol. Dr. Roswarski's most frequent co-authors are Corey Allan Carter, MD, Mark Jason Roschewski, MD and Tony R. Reid, MD.

Papers18
Years published2015 to 2023

Dr. Roswarski's papers by year, 2015 to 2023

Topics Dr. Roswarski writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • COVID-19
  • Multiple Myeloma
  • Pandemics
  • Antibodies, Monoclonal, Humanized
  • Betacoronavirus
  • Coronavirus Infections
  • Critical Illness

Dr. Roswarski's most frequent co-authors

Recent publications by Dr. Roswarski

See all 18 publications and co-authors

See who Dr. Roswarski researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Roswarski works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Joseph Lee Roswarski received $8,978 in industry payments from 2017 to 2025

CMS Open Payments shows 93 general payments to Dr. Roswarski from 31 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 46% of the total. Genmab U.S., Inc. paid the most, $2,273.

General payments to Dr. Roswarski by program year, 2017 to 2025

General payments to Dr. Roswarski by kind, 2017 to 2025

$9Kin total
  • Consulting fees$4,09046%
  • Food and beverage$3,96744%
  • Travel and lodging$85910%
  • Education$621%

Companies that paid Dr. Roswarski the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Roswarski

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Joseph Lee Roswarski graduated from Indiana University School Of Medicine

Dr. Roswarski graduated from Indiana University School Of Medicine in 2011. Dr. Roswarski is a member of ACP, ASCO and ASH.

  1. Medical schoolIndiana University School Of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Joseph Lee Roswarski accepts plans from 16 insurance carriers

Dr. Roswarski is in network with 16 carriers, including Aetna, United Healthcare and CareFirst BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Plan types Dr. Roswarski accepts, by number of carriers

  1. PPO11
  2. HMO9
  3. Medicare8
  4. EPO3
  5. POS3

Source: Dmand AI Insurance Network Data

Sources for Dr. Joseph Lee Roswarski's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Joseph Lee Roswarski

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Joseph Lee Roswarski's NPI number?

Dr. Joseph Lee Roswarski's NPI number is 1215223839. It was assigned on June 22, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Joseph Lee Roswarski?

Dr. Joseph Lee Roswarski is a hematologist and oncologist in Washington, District of Columbia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Joseph Lee Roswarski practice?

Dr. Roswarski practices at 3800 Reservoir NW Rd, Washington, DC 20007. Dr. Roswarski's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dmand AI also links Dr. Roswarski to 2 hospitals and 1 medical group.

What is Dr. Joseph Lee Roswarski's office phone number?

The practice phone on file for Dr. Roswarski is (202) 444-3000.

What is Dr. Joseph Lee Roswarski's medical license number?

Dr. Roswarski holds District of Columbia license MD210002210, one of the licenses on file in 3 states.

Which states has Dr. Joseph Lee Roswarski been licensed in?

Dmand AI has state licenses on file for Dr. Roswarski in District of Columbia (2022 to 2026), Virginia (2013 to 2026) and Maryland (2022 to 2025).

Which hospitals is Dr. Joseph Lee Roswarski affiliated with?

Dr. Roswarski is affiliated with MedStar Washington Hospital Center. Dmand AI links Dr. Roswarski to 2 more hospitals.

What medical group is Dr. Joseph Lee Roswarski part of?

Dr. Roswarski is linked to MedStar Medical Group. Dmand AI links Dr. Roswarski to 1 more medical group.

Does Dr. Joseph Lee Roswarski accept Medicare?

Yes. CMS data shows Dr. Roswarski billed Medicare for 695 services in 2024, and Dr. Roswarski accepts Medicare assignment.

Does Dr. Joseph Lee Roswarski offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Roswarski as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Joseph Lee Roswarski's MIPS score?

Dr. Roswarski's MIPS final score for performance year 2024 is 81 out of 100.

How many Medicare patients does Dr. Joseph Lee Roswarski see?

CMS counts 132 Medicare patients who saw Dr. Roswarski in 2024, with an average age of 74.

Is Dr. Joseph Lee Roswarski board certified?

Yes. Dr. Roswarski is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Joseph Lee Roswarski bill to Medicare?

In 2024, Dr. Roswarski's most billed Medicare services were hospital inpatient care (99233), medicare service (G2211) and office visit, established patient (99215).

Where did Dr. Joseph Lee Roswarski go to medical school?

Dr. Roswarski graduated from Indiana University School Of Medicine in 2011.

What drugs does Dr. Joseph Lee Roswarski prescribe most?

In 2024 Medicare Part D data, Dr. Roswarski's most prescribed drugs by claims were Brukinsa and Acyclovir.

Has Dr. Joseph Lee Roswarski received payments from drug or device companies?

CMS Open Payments shows $8,978 in general payments to Dr. Roswarski from 31 companies from 2017 to 2025. The largest total came from Genmab U.S., Inc.

How long has Dr. Joseph Lee Roswarski been practicing?

Dr. Roswarski graduated from medical school in 2011, 15 years ago.

Does Dr. Joseph Lee Roswarski do research?

Dmand AI links 18 publications to Dr. Roswarski, published from 2015 to 2023.

Who does Dr. Joseph Lee Roswarski publish with?

Dr. Roswarski's most frequent co-authors are Corey Allan Carter, MD (4 shared papers), Mark Jason Roschewski, MD (4 shared papers) and Tony R. Reid, MD (3 shared papers).

What insurance does Dr. Joseph Lee Roswarski accept?

Dr. Roswarski is in network with 16 carriers, including Aetna, United Healthcare and CareFirst BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in District of Columbia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)